Wishing All Our Readers, Sponsors, Advertisers, Listers A Happy And Prosperous Chinese New Year 2020

BREAKING NEWS
Cardiology
An informative source for all the latest about various heart ailments and new treatment or surgical protocols to manage them.
Presented by
Source: Thailand Medical News  Jan 21, 2020
Approximately 31 million people worldwide suffer from heart failure, with more than 50 per cent dying suddenly most likely due to the spontaneous onset of a heart rhythm problem, known as an arrhythmia. The link between the electrical signal that triggers the heart cell to contract (action potential) and consequent ability of the heart to pump blood has been known for nearly 40 years but understan...
Source: Thailand Medical News  Jan 06, 2020
The new guidelines and resources needed to treat fulminant myocarditis ie severe, inflammation of the heart that develops rapidly, are outlined in a new Scientific Statement from the American Heart Association on how best to reduce fatalities from this rare condition. The Statement is published today in the Association's premier cardiovascular journal Circulation. Typically, fulminant ...
Source: Thailand Medical News  Dec 24, 2019
A simple and common cardiac blood test done before surgery can predict who will experience adverse outcomes after most types of surgery, says an international study led by Hamilton Health Sciences, Ontario researchers. Worldwide, of the 280 million adults who undergo major surgery, 18 percent will experience serious cardiac and vascular complications including death within 30 day...
Source: Thailand Medical News  Dec 08, 2019
Isolating patients with otherwise stable coronary artery disease (CAD) who are high-risk and would benefit from more intense or invasive interventions is currently a major theme in cardiology research. Often CAD patients undergo a treadmill exercise test to look for signs of blockages in their coronary arteries, and Emory researchers have been examining measurements that could provide additional i...
Source: Thailand Medical News  Nov 23, 2019
A team of scientific researchers led by Massachusetts General Hospital  with support from the US National Institute of Biomedical Imaging and Bioengineering (NIBIB) has developed an improved optical imaging technique that found differences between potentially life-threatening coronary plaques and those posing less imminent danger for patients with coronary artery disease. Their method may giv...
Source: Thailand Medical News  Nov 19, 2019
Findings from a new international study involving 5179 patients at over 320 hospital locations worldwide and involving more than 20 prestigious medical universities are creating a huge buzz in the medical industry especially in the field of cardiology. Costly bypass operations, angioplasty and the placement of artery-opening stents: for decades, millions of Americans and millions worldwide have...
Source: Thailand Medical News   Oct 29, 2019
A new study by Pennsylvania State University indicates that eating one avocado daily help keep "bad cholesterol" at bay. Bad cholesterol refers to both oxidized low-density lipoprotein (LDL) and small, dense LDL particles. In a randomized, controlled study, the medical researchers found that eating one avocado a day was associated with lower levels of LDL in adults with overweight or obe...
Source : Thailand Medical News  Oct 26, 2019
There is growing evidence that the addition of triglyceride-lowering medication and lifestyle changes may be valuable in diabetes management. Due to growing evidence that moderate hypertriglyceridemia contributes to cardiovascular risk, there is a need to look at the impact of lowering triglycerides in patients with the diabetic dyslipidemia phenotype. The condition of diabetic dyslipidemia is...
Source: Thailand Medical News  Oct 04, 2019
Heart Cooling Technology has been another buzzword for the year in both the medical and biomedical engineering sectors including the race to get a new medical device to accomplish the procedure effectively in the market within the next 5 to 7 years. There are currently 3 clinical trials starting and 5 groups of teams from around the world working on such a device including Thailand but the race se...
Source: Thailand Medical News  Sep 23, 2019
Summit, the pivotal trial of Abbott Laboratories’ Tendyne transcatheter mitral valve, will not read out until 2021, but early data from a small feasibility trial of the device give a hint of how it might perform in one of Summit’s patient cohorts: those with mitral annular calcification (MAC). One-year data on the first nine patients in Abbott’s 30-patient feasibility study,...
Source: Thailand Medical News  Sep 19, 2019
Medical researchers from Washington University have successfully treated patients suffering from a potentially deadly irregular rapid heart rhythm called ventricular tachycardia with a single high dose of radiation aimed at the heart according to results of a phase one/two study. The radiation used is similar to those used to treat cancer. Radiation oncologist Dr Clifford Robinson and cardiologi...
Source: Thailand Medical News  Sep 15, 2019
The University of California San Diego and its commercial medical tech company called Ventrix, has successfully conducted a first-in-human,US  FDA-approved Phase 1 clinical trial of an injectable hydrogel that repairs damaged heart tissue and restore cardiac function in heart failure patients who previously suffered a heart attack. The hydrogel is a revolutionary material that is capable of r...
Source: Thailand Medical News  Aug 09, 2019
The German Institute for Quality and Efficiency in Health Care (IQWiG) recently conducted a study and benefit assessment commissioned by the German Federal Joint Committee (G-BA)  and found that individuals with a history of coronary heart disease (CHD) or acute coronary syndrome (ACS) benefit more from treatment with a statin in combination with ezetimibe than from statin monotherapy. Car...
Source: Thailand Medical News  Jul 08, 2019
A Strain of intestinal bacteria whose benefits were discovered in 2007 by a FNRS-WELBIO Researcher, Patrice Cani and his team at the Louvain Drug Research Institute of  The Université Catholique de Louvain  in Belgium has been in the spotlight of the medical and pharma industry in the last few months.   Patrice in  collaboration with Professor Willem de Vos from Univers...